Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

  • de Denus S
  • O’Meara E
  • Desai A
  • et al.
240Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: In their article on the Telemonitor-ing to Improve Heart Failure Outcomes (Tele-HF) trial (ClinicalTrials.gov number, NCT00303212), Chaudhry et al. (Dec. 9 issue) 1 report neutral ef-fectiveness of remote telemonitoring in patients with heart failure, in contrast to the results of a previous meta-analysis. 2 Most studies have fo-cused on patient-reported data. The risk is infor-mation overload for and noncompliance by health care professionals. In the present study, 14% of the patients did not use the intervention, and 45% of the patients did not adhere to the intervention. The World Health Organization 3 has identified patient-centered care 4 as a core component in quality health care in the 21st century, and we suggest that patient-centered care will increase the effectiveness of telemonitoring. Telemonitoring needs to focus on patients' self-care instead of reporting data. 5 Given the progressive nature of chronic heart failure and the need for extensive management of the illness, it is important that professionals and patients develop a partnership to achieve commonly agreed-on goals. How was this partnership achieved in the Tele-HF study? We suggest that modern mobile-phone technol-ogy can advance person-centered telemonitoring.

Cite

CITATION STYLE

APA

de Denus, S., O’Meara, E., Desai, A. S., Claggett, B., Lewis, E. F., Leclair, G., … Rouleau, J. L. (2017). Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation. New England Journal of Medicine, 376(17), 1690–1692. https://doi.org/10.1056/nejmc1612601

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free